BRIEF published on 07/23/2024 at 18:05, 4 months ago ABIVAX: Nombre d'actions et droits de vote au 30 juin 2024 Droits De Vote Euronext Actions AMF Abivax
BRIEF published on 07/23/2024 at 18:05, 4 months ago ABIVAX : Bilan semestriel du contrat de liquidité au 30 juin 2024 Contrat De Liquidité Transactions Financières Actions Abivax Premier Semestre 2024
BRIEF published on 07/23/2024 at 18:05, 4 months ago ABIVAX: Half-yearly review of the liquidity contract as of June 30, 2024 Liquidity Contract Actions Financial Transactions Abivax First Half Of 2024
PRESS RELEASE published on 07/23/2024 at 18:00, 4 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.06.24. ABIVAX annonce le nombre d'actions et de droits de vote au 30.06.24. Informations réglementaires conformément aux dispositions légales en vigueur Capital Droits De Vote Actions Abivax Information Réglementaire
PRESS RELEASE published on 07/23/2024 at 18:00, 4 months ago ABIVAX: Bilan semestriel du contrat de liquidité au 30 juin 2024. ABIVAX publie son bilan semestriel du contrat de liquidité au 30 juin 2024, confirmant les chiffres au 31/12/2023. Détails des transactions incluant achats, ventes et capitaux Bilan Semestriel Transactions Liquidité Abivax Capitaux
BRIEF published on 07/22/2024 at 09:51, 4 months 1 day ago Threshold crossing by Deep Track Biotechnology Master Fund Voting Rights Abivax Crossing Threshold Off-market Acquisition Deep Track Biotechnology
BRIEF published on 07/22/2024 at 09:51, 4 months 1 day ago Franchissement de seuil par Deep Track Biotechnology Master Fund Droits De Vote Franchissement De Seuil Abivax Acquisition Hors Marché Deep Track Biotechnology
PRESS RELEASE published on 07/22/2024 at 09:46, 4 months 1 day ago Franchissement de seuil Déclaration de franchissement de seuil par Deep Track Biotechnology Master Fund concernant ABIVAX Capital Droits De Vote Franchissement De Seuil Deep Track Biotechnology Master Fund Actions ABIVAX
BRIEF published on 07/15/2024 at 22:05, 4 months 8 days ago Abivax announces advances in its clinical program and updates its operations Treasury Ulcerative Colitis Nomination Update Clinical Program
BRIEF published on 07/15/2024 at 22:05, 4 months 8 days ago Abivax annonce des avancées dans son programme clinique et actualise ses opérations Nomination Trésorerie Rectocolite Hémorragique Mise À Jour Programme Clinique
Published on 11/22/2024 at 23:55, 23 hours 50 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 1 hour ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 5 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 5 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 6 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:15, 1 day 7 hours ago NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/21/2024 at 06:58, 2 days 16 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
